📣4 Coins Under $2 That Will Reach $25 in 2024

đŸȘ™Polygon (MATIC)

While many cryptocurrencies are experiencing a slowdown in gains, Polygon (MATIC) remains a standout performer in the crypto space. Breaking the $1 threshold, MATIC has recorded significant increases and shows signs of further bullish continuation above $1.70

đŸȘ™Retik Finance (RETIK)

Retik Finance is a DeFi based project, which has huge potential. The project’s main vision is to provide DeFi solutions to the crypto users around the globe. Retik Finance’s native token, RETIK, is an ERC-20 based token built on the Ethereum mainnet. The RETIK project has raised over $2.2 million without the support of venture capitalists and has also structured a presale with 10 stages, each offering incremental token prices. The ongoing success of the third stage presale indicates investor confidence in Retik Finance’s vision.

đŸȘ™Ripple (XRP)

Ripple’s XRP has navigated a series of market movements, showcasing both resilience and volatility. After trading in a closed range between $0.59 and $0.65, XRP will soon experience breakout reaching $2 and above. The subsequent bearish influence retraced gains but recently witnessed a breakout above the resistance level, indicating a potential trend reversal.

đŸȘ™Sui (SUI)

SUI, a Layer 1 blockchain token, faced a steep decline following a token unlock event on November 3. Despite the price correction, the Total Value Locked (TVL) in SUI surged past $203.29 million, signaling a bullish catalyst. Rising on-chain activity supports a positive outlook for SUI’s recovery, suggesting a potential rebound from recent corrections. As SUI’s price recovery aligns with increased on-chain engagement, the asset positions itself as a compelling candidate for those seeking opportunities in the evolving crypto landscape

📣As we move into 2024, the potential for these four cryptocurrencies under $2 to surge to $25 or beyond showcases the dynamism present in the crypto market.

$SUI $XRP $MATIC #RETIK

#DYOR。 so that you can be more informed.